Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
hepatitis B human immunoglobulin
- Development stage
- Unknown
- Lead developer
- Zhejiang Haikang Bio-Pharmaceutical
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
Hepatitis B human immunoglobulin (HBIG) from Zhejiang Haikang Biological Products is a plasma-derived biologic containing high titers of anti-HBs antibodies. It is used to provide immediate, passive immunity against the hepatitis B virus (HBV). The product is primarily indicated for the prevention of hepatitis B infection in high-risk individuals, most notably for neonatal passive immunization in infants born to HBsAg-positive mothers. It is also used for post-exposure prophylaxis following accidental exposure to HBV-contaminated blood or body fluids. As a product of Zhejiang Haikang (a subsidiary of Shanghai RAAS), it is manufactured from screened human plasma collected at specialized donation centers.
- Other names
- 乙型肝炎人免疫球蛋白Hepatitis B Human Immunoglobulin
02
Targets
HBsAg (Hepatitis B surface antigen)
Beyond the preview
Go deeper on hepatitis B human immunoglobulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on hepatitis B human immunoglobulin.